{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:52:15Z","timestamp":1791661935011,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH118344"],"award-info":[{"award-number":["R01MH118344"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012309","name":"Royal Golden Jubilee (RGJ) Ph.D. Programme","doi-asserted-by":"publisher","award":["PHD\/0106\/2561"],"award-info":[{"award-number":["PHD\/0106\/2561"]}],"id":[{"id":"10.13039\/501100012309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009726","name":"Foundation for Angelman Syndrome Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008483","name":"NOMIS Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A6A3A14043871"],"award-info":[{"award-number":["2021R1A6A3A14043871"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00359456"],"award-info":[{"award-number":["RS-2024-00359456"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A6A3A14043824"],"award-info":[{"award-number":["2021R1A6A3A14043824"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020212","name":"Swebilius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001201","name":"Kavli Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001201","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.celrep.2026.118091","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:14:27Z","timestamp":1791332067000},"page":"118091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CAR-engineered microglia harness phagocytosis to target brain tumor in organoid models"],"prefix":"10.1016","volume":"45","author":[{"given":"Mu Seog","family":"Choe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Sub","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdi Ridvan","family":"Kiral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonghun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eena","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ongnok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipon","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriporn C.","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7748-1293","authenticated-orcid":false,"given":"In-Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.118091_bib1","doi-asserted-by":"crossref","first-page":"vi1","DOI":"10.1093\/neuonc\/noae145","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017-2021","volume":"26","author":"Price","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.celrep.2026.118091_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13111536","article-title":"Advances in Glioblastoma Therapy: An Update on Current Approaches","volume":"13","author":"Angom","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.celrep.2026.118091_bib3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s11060-025-05080-3","article-title":"Survival prediction in glioblastoma: 10-year follow-up from the Dutch Neurosurgery Quality Registry","volume":"174","author":"van Dijck","year":"2025","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.celrep.2026.118091_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078943","article-title":"Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results","volume":"8","author":"Oike","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2026.118091_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-immunol-042718-041407","article-title":"Emerging Cellular Therapies for Cancer","volume":"37","author":"Guedan","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2026.118091_bib6","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.118091_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2338984","article-title":"Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012-2023)","volume":"20","author":"Miao","year":"2024","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.celrep.2026.118091_bib8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1001\/jamaoncol.2017.0184","article-title":"HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial","volume":"3","author":"Ahmed","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.celrep.2026.118091_bib9","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy","volume":"375","author":"Brown","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.118091_bib10","article-title":"A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma","volume":"9","author":"O'Rourke","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.118091_bib11","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJMoa2314390","article-title":"Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma","volume":"390","author":"Choi","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.118091_bib12","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41591-024-02893-z","article-title":"Intrathecal bivalent CAR T cells targeting EGFR and IL13Ralpha2 in recurrent glioblastoma: phase 1 trial interim results","volume":"30","author":"Bagley","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2026.118091_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41591-019-0355-0","article-title":"Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors (vol 24, pg 1459, 2018)","volume":"25","author":"Chongsathidkiet","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2026.118091_bib14","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1158\/1078-0432.CCR-17-1846","article-title":"T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma","volume":"24","author":"Woroniecka","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.118091_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41591-019-0694-x","article-title":"Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma","volume":"26","author":"Goswami","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2026.118091_bib16","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.118091_bib17","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/carcin\/bgs387","article-title":"Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes\/macrophages","volume":"34","author":"Milke","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.celrep.2026.118091_bib18","first-page":"5015","article-title":"The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients","volume":"23","author":"Ohno","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.celrep.2026.118091_bib19","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41551-025-01387-8","article-title":"Targeting inflammation with chimeric antigen receptor macrophages using a signal switch","volume":"9","author":"Cao","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.celrep.2026.118091_bib20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00262-024-03759-6","article-title":"Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers","volume":"73","author":"Chupradit","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2026.118091_bib21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2026.118091_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","article-title":"A second-generation M1-polarized CAR macrophage with antitumor efficacy","volume":"25","author":"Lei","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.118091_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jemt.1125","article-title":"Role of microglia in glioma biology","volume":"54","author":"Badie","year":"2001","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.celrep.2026.118091_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jnr.20485","article-title":"Microglia function in brain tumors","volume":"81","author":"Watters","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.celrep.2026.118091_bib25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.matbio.2013.07.008","article-title":"Review: Molecular mechanism of microglia stimulated glioblastoma invasion","volume":"32","author":"Coniglio","year":"2013","journal-title":"Matrix Biol."},{"key":"10.1016\/j.celrep.2026.118091_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2024.102877","article-title":"Microglia phagocytic mechanisms: Development informing disease","volume":"86","author":"Beiter","year":"2024","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.celrep.2026.118091_bib27","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s12035-013-8620-6","article-title":"Phagocytosis of microglia in the central nervous system diseases","volume":"49","author":"Fu","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.celrep.2026.118091_bib28","article-title":"The Role of Microglia in Glioblastoma","volume":"10","author":"Geribaldi-Dold\u00e1n","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2026.118091_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28043-y","article-title":"Expression of the transcription factor PU.1 induces the generation of microglia-like cells in human cortical organoids","volume":"13","author":"Cakir","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.118091_bib30","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41593-020-00730-3","article-title":"Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo","volume":"23","author":"Chiaradia","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2026.118091_bib31","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.cell.2023.04.022","article-title":"An in vivo neuroimmune organoid model to study human microglia phenotypes","volume":"186","author":"Schafer","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.118091_bib32","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41417-024-00746-y","article-title":"Genetic mutation patterns among glioblastoma patients in the Taiwanese population - insights from a single institution retrospective study","volume":"31","author":"Huang","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.celrep.2026.118091_bib33","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1158\/1078-0432.CCR-17-0890","article-title":"Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in -Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors","volume":"23","author":"Felsberg","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.118091_bib34","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/cercor\/bhh194","article-title":"Microglia in the cerebral wall of the human telencephalon at second trimester","volume":"15","author":"Rezaie","year":"2005","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.celrep.2026.118091_bib35","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nn1472","article-title":"ATP mediates rapid microglial response to local brain injury in vivo","volume":"8","author":"Davalos","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2026.118091_bib36","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1189\/jlb.0403128","article-title":"Fc\u03b3 receptor signaling in primary human microglia:: differential roles of PI-3K and Ras\/ERK MAPK pathways in phagocytosis and chemokine induction","volume":"75","author":"Song","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.celrep.2026.118091_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36688","article-title":"Chimeric antigen receptors that trigger phagocytosis","volume":"7","author":"Morrissey","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2026.118091_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1434495","article-title":"EGFRVIII and EGFR targeted chimeric antigen receptor T cell therapy in glioblastoma","volume":"14","author":"Sterner","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2026.118091_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7403747","article-title":"Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications","volume":"2017","author":"Vald\u00e9s-Rives","year":"2017","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.celrep.2026.118091_bib40","article-title":"Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM","volume":"20","author":"Liu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.celrep.2026.118091_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16111972","article-title":"Microglia in Glioblastomas: Molecular Insight and Immunotherapeutic Potential","volume":"16","author":"Nusraty","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.celrep.2026.118091_bib42","article-title":"Tumor microenvironment in glioblastoma: Current and emerging concepts","volume":"5","author":"Sharma","year":"2023","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.celrep.2026.118091_bib43","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1158\/1078-0432.CCR-14-2520","article-title":"Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 \u201cDon't Eat Me\u201d Signals","volume":"21","author":"McCracken","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.118091_bib44","doi-asserted-by":"crossref","first-page":"e12804","DOI":"10.1111\/sji.12804","article-title":"The MHC class I-LILRB1 signalling axis as a promising target in cancer therapy","volume":"90","author":"Zhao","year":"2019","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.celrep.2026.118091_bib45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.canlet.2018.01.050","article-title":"Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy","volume":"419","author":"Wu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.celrep.2026.118091_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1158\/2159-8290.CD-20-0556","article-title":"Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against Cancer","volume":"11","author":"Daher","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2026.118091_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.celrep.2026.118091_bib48","article-title":"CAR-T cell therapy in multiple myeloma: Current limitations and potential strategies","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.118091_bib49","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#","article-title":"Signaling pathways in phagocytosis","volume":"21","author":"Kwiatkowska","year":"1999","journal-title":"Bioessays"},{"key":"10.1016\/j.celrep.2026.118091_bib50","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nri3244","article-title":"Information processing during phagocytosis","volume":"12","author":"Underhill","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2026.118091_bib51","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41467-020-20599-x","article-title":"Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma","volume":"12","author":"Agliardi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.118091_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006239","article-title":"IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM","volume":"11","author":"Zannikou","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celrep.2026.118091_bib53","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1016\/j.ymthe.2024.07.020","article-title":"Armored bicistronic CAR T cells with dominant-negative TGF-beta receptor II to overcome resistance in glioblastoma","volume":"32","author":"Li","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celrep.2026.118091_bib54","article-title":"CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokines","volume":"6","author":"Look","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celrep.2026.118091_bib55","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s43018-023-00709-6","article-title":"Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial","volume":"5","author":"Bagley","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.celrep.2026.118091_bib57","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.118091_bib58","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","article-title":"The single-cell transcriptional landscape of mammalian organogenesis","volume":"566","author":"Cao","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.118091_bib56","doi-asserted-by":"crossref","first-page":"16464","DOI":"10.1096\/fj.202000372R","article-title":"A simple metastatic brain cancer model using human embryonic stem cell-derived cerebral organoids","volume":"34","author":"Choe","year":"2020","journal-title":"FASEB J."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726011708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726011708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:46:24Z","timestamp":1791661584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726011708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2211124726011708"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.118091","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CAR-engineered microglia harness phagocytosis to target brain tumor in organoid models","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.118091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118091"}}